Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 49

1.

CTCF facilitates DNA double-strand break repair by enhancing homologous recombination repair.

Hilmi K, Jangal M, Marques M, Zhao T, Saad A, Zhang C, Luo VM, Syme A, Rejon C, Yu Z, Krum A, Fabian MR, Richard S, Alaoui-Jamali M, Orthwein A, McCaffrey L, Witcher M.

Sci Adv. 2017 May 24;3(5):e1601898. doi: 10.1126/sciadv.1601898. eCollection 2017 May.

2.

Loss of the Par3 Polarity Protein Promotes Breast Tumorigenesis and Metastasis.

McCaffrey LM, Montalbano J, Mihai C, Macara IG.

Cancer Cell. 2016 Aug 8;30(2):351-352. doi: 10.1016/j.ccell.2016.07.001. Epub 2016 Aug 8. No abstract available.

PMID:
27505675
3.

Cell Polarity Proteins in Breast Cancer Progression.

Rejon C, Al-Masri M, McCaffrey L.

J Cell Biochem. 2016 Oct;117(10):2215-23. doi: 10.1002/jcb.25553. Epub 2016 Jun 30.

PMID:
27362918
4.

Cell polarity as a tumor suppressive mechanism.

Al-Masri M, McCaffrey L.

Oncoscience. 2015 Sep 14;2(10):791-2. eCollection 2015. No abstract available.

5.

Atypical protein kinase C induces cell transformation by disrupting Hippo/Yap signaling.

Archibald A, Al-Masri M, Liew-Spilger A, McCaffrey L.

Mol Biol Cell. 2015 Oct 15;26(20):3578-95. doi: 10.1091/mbc.E15-05-0265. Epub 2015 Aug 12.

6.

Oncogenic suppression of apoptosis uncovers a Rac1/JNK proliferation pathway activated by loss of Par3.

Archibald A, Mihai C, Macara IG, McCaffrey L.

Oncogene. 2015 Jun 11;34(24):3199-206. doi: 10.1038/onc.2014.242. Epub 2014 Aug 11.

7.

Emerging role of cell polarity proteins in breast cancer progression and metastasis.

Chatterjee SJ, McCaffrey L.

Breast Cancer (Dove Med Press). 2014 Jan 9;6:15-27. doi: 10.2147/BCTT.S43764. eCollection 2014. Review.

8.

Rewiring cell polarity signaling in cancer.

Halaoui R, McCaffrey L.

Oncogene. 2015 Feb 19;34(8):939-50. doi: 10.1038/onc.2014.59. Epub 2014 Mar 17. Review.

PMID:
24632617
9.

Cell polarity in morphogenesis and metastasis.

Macara IG, McCaffrey L.

Philos Trans R Soc Lond B Biol Sci. 2013 Sep 23;368(1629):20130012. doi: 10.1098/rstb.2013.0012. Print 2013. Review.

10.

Results of a follow-up study to the randomized Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT).

Alzheimer's Disease Anti-inflammatory Prevention Trial Research Group.

Alzheimers Dement. 2013 Nov;9(6):714-23. doi: 10.1016/j.jalz.2012.11.012. Epub 2013 Apr 3.

11.

Comparison of treatment regimens for cytomegalovirus retinitis in patients with AIDS in the era of highly active antiretroviral therapy.

Jabs DA, Ahuja A, Van Natta M, Dunn JP, Yeh S; Studies of the Ocular Complications of AIDS Research Group.

Ophthalmology. 2013 Jun;120(6):1262-70. doi: 10.1016/j.ophtha.2012.11.023. Epub 2013 Feb 16.

12.

Loss of the Par3 polarity protein promotes breast tumorigenesis and metastasis.

McCaffrey LM, Montalbano J, Mihai C, Macara IG.

Cancer Cell. 2012 Nov 13;22(5):601-14. doi: 10.1016/j.ccr.2012.10.003.

13.

Non-cytomegalovirus ocular opportunistic infections in patients with acquired immunodeficiency syndrome.

Gangaputra S, Drye L, Vaidya V, Thorne JE, Jabs DA, Lyon AT; Studies of the Ocular Complications of AIDS (SOCA) Research Group.

Am J Ophthalmol. 2013 Feb;155(2):206-212.e5. doi: 10.1016/j.ajo.2012.07.019. Epub 2012 Oct 12.

14.

Signaling pathways in cell polarity.

McCaffrey LM, Macara IG.

Cold Spring Harb Perspect Biol. 2012 Jun 1;4(6). pii: a009654. doi: 10.1101/cshperspect.a009654.

15.

Incidence of cytomegalovirus retinitis in the era of highly active antiretroviral therapy.

Sugar EA, Jabs DA, Ahuja A, Thorne JE, Danis RP, Meinert CL; Studies of the Ocular Complications of AIDS Research Group.

Am J Ophthalmol. 2012 Jun;153(6):1016-24.e5. doi: 10.1016/j.ajo.2011.11.014. Epub 2012 Feb 4.

17.

Epithelial organization, cell polarity and tumorigenesis.

McCaffrey LM, Macara IG.

Trends Cell Biol. 2011 Dec;21(12):727-35. doi: 10.1016/j.tcb.2011.06.005. Epub 2011 Jul 21. Review.

PMID:
21782440
18.

Evaluation of the United States public health service guidelines for discontinuation of anticytomegalovirus therapy after immune recovery in patients with cytomegalovirus retinitis.

Holbrook JT, Colvin R, van Natta ML, Thorne JE, Bardsley M, Jabs DA; Studies of Ocular Complications of AIDS (SOCA) Research Group.

Am J Ophthalmol. 2011 Oct;152(4):628-637.e1. doi: 10.1016/j.ajo.2011.04.007. Epub 2011 Jul 13.

19.

Association of host genetic risk factors with the course of cytomegalovirus retinitis in patients infected with human immunodeficiency virus.

Sezgin E, van Natta ML, Ahuja A, Lyon A, Srivastava S, Troyer JL, O'Brien SJ, Jabs DA; Studies of the Ocular Complications of AIDS Research Group.

Am J Ophthalmol. 2011 Jun;151(6):999-1006.e4. doi: 10.1016/j.ajo.2010.11.029. Epub 2011 Mar 10.

20.

Excess mortality in patients with AIDS in the era of highly active antiretroviral therapy: temporal changes and risk factors.

Puhan MA, Van Natta ML, Palella FJ, Addessi A, Meinert C; Ocular Complications of AIDS Research Group.

Clin Infect Dis. 2010 Oct 15;51(8):947-56. doi: 10.1086/656415.

Supplemental Content

Loading ...
Support Center